SCHEMBL5506645

SCHEMBL5506645

CC(C)(C)OC(=O)NCC1CCCC(C(=O)N(C#N)c2cccc3cccnc23)C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
ACACB O00763 7/20 0.39
ACACA Q13085 5/20 0.38
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
POLB P06746 1/20 0.36
DRD2 P14416 1/20 0.35
JAK1 P23458 2/20 0.35
JAK2 O60674 1/20 0.35
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
IRAK1 P51617 1/20 0.35
HTR5A P47898 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5432646 0.87 CNR1 (0.40) KDM4EL3MBTL1CNR1CNR2ACACB
SCHEMBL3584611 0.80 KDM4E (0.36) KDM4EL3MBTL1ALDH1A1HPGDPOLB
SCHEMBL4039798 0.80 KDM4E (0.36) KDM4EL3MBTL1ALDH1A1HPGDPOLB
SCHEMBL5530322 0.76 ACACB (0.40) KDM4ECNR1CNR2ACACBACACA
SCHEMBL5506640 0.73 PLAU (0.40) CNR1CNR2ACACBACACACKS1B
SCHEMBL5432642 0.69 PLAU (0.41) CNR1CNR2ACACBACACACKS1B
SCHEMBL13590682 0.69 HPGD (0.64) ACACBACACAALDH1A1HPGDPOLB
SCHEMBL2369250 0.68 ACACB (0.48) ACACBACACAHPGDCKS1BSKP1
SCHEMBL7246825 0.67 BTK (0.61) L3MBTL1ACACBACACACKS1BSKP1
SCHEMBL5262829 0.67 BTK (0.61) L3MBTL1ACACBACACACKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799676-A2 NEW BICYCLIC ANTIBIOTICS Actelion Pharmaceuticals Ltd. (CH) 2007-06-27 EP disclosed
WO-2006032466-A2 NEW BICYCLIC ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-30 WO disclosed